Trials / Unknown
UnknownNCT01886092
Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus
Verification of the Usefulness of the Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Tinnitus
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy of different protocols of transcranial magnetic stimulation for the treatment of tinnitus
Detailed description
Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex has an add-on effect for primary auditory cortex rTMS in improving tinnitus-related distress. The investigators aimed to investigate whether rTMS of the dorsolateral prefrontal cortex and primary auditory cortex are capable of reducing tinnitus loudness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active rTMS 1 | repetitive transcranial magnetic stimulation (Figured 8-Coil Cool-B65): 1000 stimuli of 1Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) followed by 2000 stimuli of 1 Hz rTMS over the left primary auditory cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects). |
| DEVICE | Active rTMS 2 | repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left temporal cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects) |
| DEVICE | Active rTMS 3 | repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) each consisting of 4 days of rTMS treatment. (20 subjects) |
| DEVICE | sham condition | Sham rTMS, applied with the same combination of parameters as active rTMS, except for the number of stimulations per session. (20 subjects) |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2019-09-01
- Completion
- 2020-10-01
- First posted
- 2013-06-25
- Last updated
- 2018-10-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01886092. Inclusion in this directory is not an endorsement.